Saturday, June 13, 2026

Patent directory · USPTO A61K / A61P

Browse patents

Browse 30,257 pharma-relevant patents (US A61K/A61P) linked to tracked companies, drugs, and pipeline programs.

Patents indexed 30,257
Companies 1,769
Drugs linked 4,797

Quick answer

NovaPharmaNews indexes 30,257 US pharmaceutical patents from USPTO PatentsView (CPC A61K/A61P), cross-linked to company assignees, drug INN profiles, and pipeline programs. Search by patent number, applicant, title, or CPC code — or use facet hubs for expiring patents, assignees, and therapeutic areas.

Patent results

Page 219 of 1,261
  1. US 11535650

    Modulation of complement activity

    RA PHARMACEUTICALS, INC. · Granted Dec 27, 2022 · Expires Dec 22, 2042

    granted
  2. US 11535651

    Hepatitis B nanoparticle-based vaccine for influenza virus

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Dec 27, 2022 · Expires Dec 22, 2042

    granted
  3. US 11536727

    Therapeutic antibodies against ROR-1 protein and methods for use of same

    The Regents of the University of California · Granted Dec 27, 2022 · Expires Dec 22, 2042

    granted
  4. US 11535870

    Adeno-associated virus vectors encoding modified G6PC and uses thereof

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Dec 27, 2022 · Expires Dec 22, 2042

    granted
  5. US 11535851

    Reagents for treatment of hepatitis B virus (HBV) infection and use thereof

    Benitec IP Holdings Inc. · Granted Dec 27, 2022 · Expires Dec 22, 2042

    granted
  6. US 11535663

    Methods for producing aflibercept in chemically defined media having reduced aflibercept variants

    REGENERON PHARMACEUTICALS, INC. · Granted Dec 27, 2022 · Expires Dec 22, 2042

    granted
  7. US 11535773

    Coatings containing polymer modified enzyme for stable self-cleaning of organic stains

    Regents of the University of Minnesota · Granted Dec 27, 2022 · Expires Dec 22, 2042

    granted
  8. US 11535684

    Chitosan derivatives and methods for preparing the same

    PRIMEX EHF · Granted Dec 27, 2022 · Expires Dec 22, 2042

    granted
  9. US 11535677

    Chimeric antigen receptors targeting BCMA and methods of use thereof

    LEGEND BIOTECH USA INC. · Granted Dec 27, 2022 · Expires Dec 22, 2042

    granted
  10. US 11535675

    Antigen-binding proteins that antagonize leptin receptor

    REGENERON PHARMACEUTICALS, INC. · Granted Dec 27, 2022 · Expires Dec 22, 2042

    granted
  11. US 11535648

    Isolated darobactin A analog compounds and compositions thereof

    Northwestern University · Granted Dec 27, 2022 · Expires Dec 22, 2042

    granted
  12. US 11534495

    Tissue factor-targeted antibody-drug conjugate

    SHANGHAI MIRACOGEN INC. · Granted Dec 27, 2022 · Expires Dec 22, 2042

    granted
  13. US 11534453

    RNAi therapy for hepatitis B virus infection

    Arrowhead Pharmaceuticals, Inc. · Granted Dec 27, 2022 · Expires Dec 22, 2042

    granted
  14. US 11534463

    Nucleic acids encoding kynurenine depleting enzymes

    The Board of Regents of the University of Texas System · Granted Dec 27, 2022 · Expires Dec 22, 2042

    granted
  15. US 11534465

    Fecal matter for treatment of autoimmune diseases

    ACADEMISCH MEDISCH CENTRUM · Granted Dec 27, 2022 · Expires Dec 22, 2042

    granted
  16. US 11534397

    Nanocrystal microparticles of poorly soluble drugs and methods of production and use thereof

    The Board of Regents of the University of Oklahoma · Granted Dec 27, 2022 · Expires Dec 22, 2042

    granted
  17. US 11534333

    Skin-like condoms having active ingredients to enhance a male erection and a female arousal

    ARIZONA BOARD OF REGENTS FOR AND ON BEHALF OF ARIZONA STATE UNIVERSITY · Granted Dec 27, 2022 · Expires Dec 22, 2042

    granted
  18. US 11534427

    Applications of novel thiazole derivative in treating inflammatory bowel diseases

    East China University of Science and Technology · Granted Dec 27, 2022 · Expires Dec 22, 2042

    granted
  19. US 11534430

    Treatment of asthma and chronic obstructive pulmonary disease with anti-proliferate and anti-inflammatory drugs

    Lutonix, Inc. · Granted Dec 27, 2022 · Expires Dec 22, 2042

    granted
  20. US 11535658

    Activatable interleukin-2 polypeptides and methods of use thereof

    Werewolf Therapeutics, Inc. · Granted Dec 27, 2022 · Expires Dec 22, 2042

    granted
  21. US 11534439

    Dihydroquinoxaline and dihydropyridopyrazine derivatives as RSV inhibitors

    Enanta Pharmaceuticals, Inc. · Granted Dec 27, 2022 · Expires Dec 22, 2042

    granted
  22. US 11533915

    Methods for making and using antimicrobial peptides

    Regents of the University of Minnesota · Granted Dec 27, 2022 · Expires Dec 22, 2042

    granted
  23. US 11534429

    Small molecule inhibitors of bacterial efflux pumps and methods of using same

    The Regents of the University of Colorado · Granted Dec 27, 2022 · Expires Dec 22, 2042

    granted
  24. US 11535869

    CD8-specific antibody constructs and compositions thereof

    Sana Biotechnology, Inc. · Granted Dec 27, 2022 · Expires Dec 22, 2042

    granted

Frequently asked questions

What patents are included in this directory?

We index 30,257 published US pharma-relevant patents filtered to CPC classes A61K and A61P, with assignee links to our company directory where a match exists.

How do I search for a patent?

Use the search box to match patent number, title, applicant name, or CPC classification (e.g. A61K). For cross-entity queries spanning news and drugs, use the global search.

How is this different from the patent intelligence dashboard?

The dashboard at /patents highlights expirations, recent grants, and assignee rankings. Browse is the full paginated directory with search — best for looking up a specific filing or applicant portfolio slice.